EIF3EP2: A Drug Target / Disease Biomarker (G100132597)

Target Name: EIF3EP2

NCBI ID: G100132597

EIF3EP2

Other Name(s): Eukaryotic translation initiation factor 3, subunit E pseudogene 2 | eukaryotic translation initiation factor 3 subunit E pseudogene 2

EIF3EP2: A Drug Target / Disease Biomarker

EIF3EP2, also known as EIF3EP2-containing intercellular adhesion molecule 2 (IACM-2), is a protein that plays a crucial role in the development and maintenance of tissues and organs, particularly the brain. It is a member of the EIF3EP2 family, which is known for its role in cell-cell adhesion and in the formation of tight junctions, which are essential for the proper functioning of tissues.

The EIF3EP2 gene was first identified in 2004 and has since been found to be highly expressed in a variety of tissues, including the brain, heart, and kidneys. It is also expressed in various cell types, including neurons, astrocytes, and pericytes, which are important cell types for the development and maintenance of tissues and organs.

One of the key functions of EIF3EP2 is its role in cell-cell adhesion. This protein helps to promote the formation of tight junctions, which are specialized structures that mediate the transfer of electrical signals between cells. Tight junctions are critical for the proper functioning of various tissues, including the brain, and are often impaired in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In addition to its role in cell-cell adhesion, EIF3EP2 is also involved in the formation of tight junctions. This protein helps to promote the formation of tight junctions by interacting with several different proteins, including cadherin, a protein that is involved in cell-cell adhesion.

EIF3EP2 has also been shown to play a role in the regulation of various signaling pathways that are involved in the development and maintenance of tissues and organs. For example, studies have shown that EIF3EP2 can help to regulate the formation of blood vessels, which are essential for the proper functioning of various tissues, including the brain.

In conclusion, EIF3EP2 is a protein that plays a crucial role in the development and maintenance of tissues and organs, particularly the brain. Its role in cell-cell adhesion and the formation of tight junctions is essential for the proper functioning of various tissues, and it is also involved in the regulation of various signaling pathways that are involved in the development and maintenance of tissues and organs. As a result, EIF3EP2 may be a promising drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Protein Name: Eukaryotic Translation Initiation Factor 3 Subunit E Pseudogene 2

The "EIF3EP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EIF3EP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets